Diana Hausman Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity
Diana Hausman is Chief Medical Officer of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 373,876 shares of ZNTL, which is worth approximately $1.24 Million. The most recent transaction as insider was on May 09, 2024, when has been sold 3,356 shares (Common Stock) at a price of $12.62 per share, resulting in proceeds of $42,352. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
374K
0%
3M change
840.99%
12M change
Total Value Held
$1.24 Million
DIANA HAUSMAN Transaction History
Also insider at
DH
Diana Hausman
Chief Medical Officer
Vancouver, A1